Cargando…

Therapeutic strategies of different HPV status in Head and Neck Squamous Cell Carcinoma

Head and neck squamous cell carcinoma (HNSCC) is the 9(th) most common malignant tumor in the world. Based on the etiology, HNSCC has two main subtypes: human papillomavirus (HPV) -related and HPV-unrelated. HPV-positive HNSCC is more sensitive to treatment with favorable survival. Due to the differ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Yingming, Wang, Zhe, Qiu, Sufang, Wang, Ruoyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040311/ https://www.ncbi.nlm.nih.gov/pubmed/33867833 http://dx.doi.org/10.7150/ijbs.58077

Ejemplares similares

De-Escalating Strategies in HPV-Associated Head and Neck Squamous Cell Carcinoma
por: Economopoulou, Panagiota, et al.
Publicado: (2021)

Radioimmunotherapy in HPV-Associated Head and Neck Squamous Cell Carcinoma
por: Zhou, Xin, et al.
Publicado: (2022)

Radiosensitization approaches for HPV‐positive and HPV‐negative head and neck squamous carcinomas
por: Dok, Rüveyda, et al.
Publicado: (2019)

The radiobiology of HPV-positive and HPV-negative head and neck squamous cell carcinoma
por: Zhou, Chumin, et al.
Publicado: (2020)

Implications and Emerging Therapeutic Avenues of Inflammatory Response in HPV+ Head and Neck Squamous Cell Carcinoma
por: Castellano, Lúcio Roberto Cançado, et al.
Publicado: (2022)

Peripheral Cytokine Levels Differ by HPV Status and Change Treatment-Dependently in Patients with Head and Neck Squamous Cell Carcinoma
por: Mytilineos, Daphne, et al.
Publicado: (2020)

Comprehensive analysis of mitophagy in HPV-related head and neck squamous cell carcinoma
por: Yanan, Li, et al.
Publicado: (2023)

Advancements in the Management of HPV-Associated Head and Neck Squamous Cell Carcinoma
por: Zeitlin, Ross, et al.
Publicado: (2015)

HPV Detection in Head and Neck Squamous Cell Carcinomas: What Is the Issue?
por: Augustin, Jeremy Gbenakpon, et al.
Publicado: (2020)

Single-Cell Transcriptome Analysis Reveals Different Immune Signatures in HPV- and HPV + Driven Human Head and Neck Squamous Cell Carcinoma
por: Li, Simin, et al.
Publicado: (2022)

Characteristics of B lymphocyte infiltration in HPV(+) head and neck squamous cell carcinoma
por: Zhang, Siwei, et al.
Publicado: (2021)

Immunological Network in Head and Neck Squamous Cell Carcinoma—A Prognostic Tool Beyond HPV Status
por: Fialová, Anna, et al.
Publicado: (2020)

HPV-Related Prognostic Signature Predicts Survival in Head and Neck Squamous Cell Carcinoma
por: Zhao, Hongyu, et al.
Publicado: (2022)

A HPV16-related prognostic indicator for head and neck squamous cell carcinoma
por: Zhang, Qian, et al.
Publicado: (2020)

Adaptive immune resistance in HPV-associated head and neck squamous cell carcinoma
por: Pai, Sara I.
Publicado: (2013)

Management of HPV-Related Squamous Cell Carcinoma of the Head and Neck: Pitfalls and Caveat
por: Perri, Francesco, et al.
Publicado: (2020)

An Immunocompetent Mouse Model of HPV16(+) Head and Neck Squamous Cell Carcinoma
por: Carper, Miranda B., et al.
Publicado: (2019)

PYHIN Proteins and HPV: Role in the Pathogenesis of Head and Neck Squamous Cell Carcinoma
por: Riva, Giuseppe, et al.
Publicado: (2019)

Mechanisms of Cisplatin Resistance in HPV Negative Head and Neck Squamous Cell Carcinomas
por: Griso, Ana Belén, et al.
Publicado: (2022)

Proteome and phosphoproteome signatures of recurrence for HPV(+) head and neck squamous cell carcinoma
por: Kaneko, Tomonori, et al.
Publicado: (2022)

Efficacy of cetuximab plus PD-1 inhibitor differs by HPV status in head and neck squamous cell carcinoma: a systematic review and meta-analysis
por: Zhang, Siqi, et al.
Publicado: (2022)

Therapeutic Targeting of MYC in Head and Neck Squamous Cell Carcinoma
por: Liu, Shuo, et al.
Publicado: (2022)

HPV-positive status associated with inflamed immune microenvironment and improved response to anti-PD-1 therapy in head and neck squamous cell carcinoma
por: Wang, Jian, et al.
Publicado: (2019)

In vitro effects of gamma-secretase inhibition in HPV-positive and HPV-negative head and neck squamous cell carcinoma
por: Varatanovic, Sara, et al.
Publicado: (2023)

Heterogeneous nuclear ribonucleoprotein K is overexpressed and contributes to radioresistance irrespective of HPV status in head and neck squamous cell carcinoma
por: Kähler, Justus, et al.
Publicado: (2020)

High USP4 mRNA is associated with an HPV-positive status in head and neck squamous cell carcinoma patients
por: Scheiflinger, Alexandra, et al.
Publicado: (2023)

The Prognostic Role of Cuproptosis in Head and Neck Squamous Cell Carcinoma Patients: A Comprehensive Analysis
por: Ding, Qin, et al.
Publicado: (2022)

Current Therapeutic Strategies in Patients with Oropharyngeal Squamous Cell Carcinoma: Impact of the Tumor HPV Status
por: Bozec, Alexandre, et al.
Publicado: (2021)

Induction of heparanase by HPV E6 oncogene in head and neck squamous cell carcinoma
por: Hirshoren, Nir, et al.
Publicado: (2014)

Identification and functional validation of HPV-mediated hypermethylation in head and neck squamous cell carcinoma
por: Lechner, Matthias, et al.
Publicado: (2013)

Oncolytic activity of reovirus in HPV positive and negative head and neck squamous cell carcinoma
por: Cooper, Timothy, et al.
Publicado: (2015)

HPV, tumour metabolism and novel target identification in head and neck squamous cell carcinoma
por: Fleming, Jason C., et al.
Publicado: (2019)

Unique DNA methylation signature in HPV-positive head and neck squamous cell carcinomas
por: Degli Esposti, Davide, et al.
Publicado: (2017)

HPV Involvement in the Tumor Microenvironment and Immune Treatment in Head and Neck Squamous Cell Carcinomas
por: Lechien, Jérôme R., et al.
Publicado: (2020)

Causes and Consequences of HPV Integration in Head and Neck Squamous Cell Carcinomas: State of the Art
por: Balaji, Harini, et al.
Publicado: (2021)

The Role of HPV in Determining Treatment, Survival, and Prognosis of Head and Neck Squamous Cell Carcinoma
por: Sharkey Ochoa, Imogen, et al.
Publicado: (2022)

FDCSP Is an Immune-Associated Prognostic Biomarker in HPV-Positive Head and Neck Squamous Carcinoma
por: Wu, Qingqing, et al.
Publicado: (2022)

De-Escalation Strategies of (Chemo)Radiation for Head-and-Neck Squamous Cell Cancers—HPV and Beyond
por: Rühle, Alexander, et al.
Publicado: (2021)

Targeting epigenetic modulation of cholesterol synthesis as a therapeutic strategy for head and neck squamous cell carcinoma
por: Xu, Xing, et al.
Publicado: (2021)

LRP1B mutation is associated with tumor HPV status and promotes poor disease outcomes with a higher mutation count in HPV-related cervical carcinoma and head & neck squamous cell carcinoma
por: Cao, Can-hui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5bueenphast4vt8hhp43ed0h7c